Suppr超能文献

衰老相关糖尿病:为临床指导开发循证依据的途径。

Diabetes in ageing: pathways for developing the evidence base for clinical guidance.

机构信息

Harvard Medical School, Boston, MA, USA; Joslin Diabetes Center, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA.

University of British Columbia, Vancouver, BC, Canada.

出版信息

Lancet Diabetes Endocrinol. 2020 Oct;8(10):855-867. doi: 10.1016/S2213-8587(20)30230-8.

Abstract

Older adults with diabetes are heterogeneous in their medical, functional, and cognitive status, and require careful individualisation of their treatment regimens. However, in the absence of detailed information from clinical trials involving older people with varying characteristics, there is little evidence-based guidance, which is a notable limitation of current approaches to care. It is important to recognise that older people with diabetes might vary in their profiles according to age category, functional health, presence of frailty, and comorbidity profiles. In addition, all older adults with diabetes require an individualised approach to care, ranging from robust individuals to those residing in care homes with a short life expectancy, those requiring palliative care, or those requiring end-of-life management. In this Review, our multidisciplinary team of experts describes the current evidence in several important areas in geriatric diabetes, and outlines key research gaps and research questions in each of these areas with the aim to develop evidence-based recommendations to improve the outcomes of interest in older adults.

摘要

患有糖尿病的老年人在其医疗、功能和认知状况方面存在差异,需要对其治疗方案进行仔细的个体化调整。然而,由于缺乏涉及具有不同特征的老年人的临床试验的详细信息,因此几乎没有循证指导,这是当前护理方法的一个显著局限性。重要的是要认识到,患有糖尿病的老年人可能根据年龄类别、功能健康、是否存在虚弱以及合并症的情况而在其特征上存在差异。此外,所有患有糖尿病的老年人都需要采用个体化的护理方法,范围从身体健壮的人到预期寿命较短的居住在养老院的人、需要姑息治疗的人或需要临终管理的人。在这篇综述中,我们由多学科专家组成的团队描述了老年糖尿病几个重要领域的现有证据,并概述了这些领域中的关键研究空白和研究问题,旨在制定循证建议以改善老年人的相关结果。

相似文献

1
Diabetes in ageing: pathways for developing the evidence base for clinical guidance.
Lancet Diabetes Endocrinol. 2020 Oct;8(10):855-867. doi: 10.1016/S2213-8587(20)30230-8.
3
Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
Geriatr Gerontol Int. 2021 Aug;21(8):601-613. doi: 10.1111/ggi.14201. Epub 2021 Jul 1.
6
Managing diabetes in people with dementia: a realist review.
Health Technol Assess. 2017 Dec;21(75):1-140. doi: 10.3310/hta21750.
7
New horizons in clinical practice guidelines for use with older people.
Age Ageing. 2024 Jul 2;53(7). doi: 10.1093/ageing/afae158.
8
Developing clinical guidelines for end-of-life care: blending evidence and consensus.
Int J Palliat Nurs. 2012 Aug;18(8):397-405. doi: 10.12968/ijpn.2012.18.8.397.
10
Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies.
Diabetologia. 2018 Jul;61(7):1503-1516. doi: 10.1007/s00125-018-4547-9. Epub 2018 Feb 7.

引用本文的文献

3
The efficacy of intermittent scanning continuous glucose monitoring in the elderly: A case-control study.
Diabetes Obes Metab. 2025 Jul;27(7):3882-3890. doi: 10.1111/dom.16417. Epub 2025 May 13.
4
Assessment of Glycemic Control Using Continuous Glucose Monitoring During Hospitalization and After Discharge for Older Adults.
J Diabetes Sci Technol. 2025 Apr 12:19322968251332656. doi: 10.1177/19322968251332656.
5
How do sex-specific BMI trajectories shape diabetes risk? A longitudinal analysis of Indonesian adults.
BMJ Public Health. 2023 Nov 6;1(1):e000020. doi: 10.1136/bmjph-2023-000020. eCollection 2023 Nov.
6
Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies.
Lancet Diabetes Endocrinol. 2025 May;13(5):427-437. doi: 10.1016/S2213-8587(24)00372-3. Epub 2025 Feb 17.
7
Long-term frailty and physical performance transitions in older people with type-2 diabetes. The MIDFRAIL randomized clinical study.
J Nutr Health Aging. 2025 Apr;29(4):100512. doi: 10.1016/j.jnha.2025.100512. Epub 2025 Feb 14.
10
Nutritional Interventions in Older Persons with Type 2 Diabetes and Frailty: A Scoping Systematic Review.
J Cardiovasc Dev Dis. 2024 Sep 18;11(9):289. doi: 10.3390/jcdd11090289.

本文引用的文献

1
Diabetes and global ageing among 65-99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9 edition.
Diabetes Res Clin Pract. 2020 Apr;162:108078. doi: 10.1016/j.diabres.2020.108078. Epub 2020 Feb 14.
2
Clinical guidelines for type 1 diabetes mellitus with an emphasis on older adults: an Executive Summary.
Diabet Med. 2020 Jan;37(1):53-70. doi: 10.1111/dme.14135. Epub 2019 Sep 23.
5
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.
6
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11.
8
Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus.
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):721-733. doi: 10.1002/jcsm.12432. Epub 2019 Apr 23.
9
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
10
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. doi: 10.1210/jc.2019-00198.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验